---
title: "Tiziana Life Sciences Ltd (TLSA.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/TLSA.US.md"
symbol: "TLSA.US"
name: "Tiziana Life Sciences Ltd"
industry: "Biotechnology"
datetime: "2026-05-19T21:36:36.653Z"
locales:
  - [en](https://longbridge.com/en/quote/TLSA.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TLSA.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TLSA.US.md)
---

# Tiziana Life Sciences Ltd (TLSA.US)

## Company Overview

Tiziana Life Sciences Ltd, a biotechnology company, engages in the development of transformative therapies for neurodegenerative and lung diseases in the United States. The company’s lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for use in the treatment of Crohn’s, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It is also developing TZLS-501, a fully human mAb targeting the IL-6 receptor for use in the treatment of inflammatory and oncology indications. Tiziana Life Sciences Ltd was incorporated in 1998 and is headquartered in London, the United Kingdom.

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Exchange | US Market |
| Website | [www.tizianalifesciences.com](https://www.tizianalifesciences.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -9.32 | 443 | - | - | - |
| PB | 3303.54 | 447 | 50.41 | 23.87 | 18.99 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2025-12-29T05:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 1.38 |
| Highest Target | 8.01 |
| Lowest Target | 8.01 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/TLSA.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/TLSA.US/norm.md)
- [Related News](https://longbridge.com/en/quote/TLSA.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/TLSA.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**